Company / Operating Income per Share
Zenas BioPharma, Inc. Operating Income per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$9.17
FY2025
5-year range
-$24.26 / -$9.17
FY2023-FY2025
Trend
+61.1%
vs FY2024
Sector context
#191 of 201
Health Care
What the data says
Among 201 Health Care companies, Zenas BioPharma, Inc. is in the bottom 5% for operating income per share. Improved from $-24.26 to $-9.17 over the past 2 years.
Based on SEC 10-K filings.
-9.17 in FY2025.
Improved from $-24.26 to $-9.17 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 201This company -$9.17 Sector average -$28.56
▼
+67.9% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 61.1% year-over-year.
- Ranks #191 out of 201 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$9.17 | +61.1% |
| FY2024 | -$23.56 | +2.9% |
| FY2023 | -$24.26 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026